New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA ...

Dr Metersky provides his closing thoughts, highlighting key points of emphasis surrounding bronchiectasis care and the future of its treatment landscape. Pamela J. McShane, MD, explores the clinical ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...

This article explains the role and future prospects of dipeptidyl peptidase 1 (DPP1) inhibitors as treatments for ...

Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...

Newswise — NEW YORK, NY – JULY 1, 2026 – A lesser-known chronic lung disease, bronchiectasis affects hundreds of thousands of children and adults worldwide. Individuals living with bronchiectasis ...

Please provide your email address to receive an email when new articles are posted on . A team of experts established 13 evidence-based recommendations for managing bronchiectasis in adults. The ...

A new case report documents bronchiectasis preceding ANCA-associated vasculitis by seven years, exposing a diagnostic blind spot in current bronchiectasis guidelines.

Milan, Italy: The colour of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new ...